CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population. - Wikidata - wikimedia - TriplyDB

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

http://www.wikidata.org/entity/Q54684440

about

Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals Investigating the Role of Plasma Glucose Concentration as a Phenotypic Marker for CYP2C9 Genetic Variants, in the Diabetic Population of Gujarat Implementing genotype-guided antithrombotic therapy.Prevalence of genetic variants associated with cardiovascular disease risk and drug response in the Southern Indian population of Kerala.Genetic polymorphism of drug refractory epilepsy Analysis of CYP2C9*2, CYP2C9*3 and VKORC1 -1639 G>A polymorphisms in a population from South-Eastern Europe.A study on the impact of CYP2C19 genotype and platelet reactivity assay on patients undergoing PCI Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy.Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine Genetic variation and haplotype structure of the gene Vitamin K epoxide reductase complex, subunit 1 in the Tamilian population.Cytochrome P450 (CYP2C9*2,*3) & vitamin-K epoxide reductase complex (VKORC1 -1639G<A) gene polymorphisms & their effect on acenocoumarol dose in patients with mechanical heart valve replacement.Evaluation of cytochrome P450 2C9 activity in normal, healthy, adult Western Indian population by both phenotyping and genotyping.Evaluation of CYP2C19, P2Y12, and ABCB1 polymorphisms and phenotypic response to clopidogrel in healthy Indian adults Inter and intra ethnic variation of vitamin K epoxide reductase complex and cytochrome P450 4F2 genetic polymorphisms and their prevalence in South Indian population.Influence of Ethnicity, Age, and Time on Sex Disparities in Long-Term Cause-Specific Mortality After Acute Myocardial Infarction.Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.High prevalence of CYP2C19*2 allele in Roma samples: study on Roma and Hungarian population samples with review of the literature.Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.Association of polymorphism in cytochrome P450 2C9 with susceptibility to head and neck cancer and treatment outcome.Genetic Polymorphism of Cytochrome p450 (2C9) Enzyme in Iranian Baluch Ethnic Group Correlation of CYP2C19 genotype with plasma voriconazole levels: a preliminary retrospective study in Indians.Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR.Frequency of selected single nucleotide polymorphisms influencing the warfarin pharmacogenetics in Slovak population.Association of cytochrome P450 2C9 polymorphism with locally advanced head and neck squamous cell carcinoma and response to concurrent cisplatin-based radical chemoradiation Genetic Polymorphism of Cytochrome p450 (2C19) Enzyme in Iranian Turkman Ethnic Group.The value of combining CYP2C19*2 polymorphism with classic risk factors in prediction of clinical prognosis in acute coronary syndrome patients.CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database.Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population.Genotype-phenotype correlation of cytochrome P450 2C9 polymorphism in Indian National Capital Region.Effect of 36 CYP2C9 variants found in the Chinese population on losartan metabolism in vitro.Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population.CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes and phenytoin adverse reactions correlation.Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel.Pharmacogenetics-Based Warfarin Dosing in Patients With Cardiac Valve Replacement: The Effects of CYP2C9 and VKORC1 Gene Polymorphisms.CYP2C19 and PON1 polymorphisms regulating clopidogrel bioactivation in Chinese, Malay and Indian subjects.Distribution of CYP2C8 and CYP2C9 amino acid substitution alleles in South Indian diabetes patients: A genotypic and computational protein phenotype study.An acenocoumarol dosing algorithm exploiting clinical and genetic factors in South Indian (Dravidian) population.Optimization of warfarin dose by population-specific pharmacogenomic algorithm.Effect of antituberculosis treatment on CYP2C19 enzyme activity in genetically polymorphic South Indian Tamilian population.CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment.

P2860

Q28237144-C3073E6B-D3B9-4C07-941F-C88D55215231 Q33555327-47D51EB2-1571-412B-B511-A87403DA4462 Q33990428-81A28276-3855-4224-97A6-DE43FAC291D1 Q34494596-2159EB7C-D1EC-423C-AA0B-97396DD3B0FD Q35351642-47DD89A6-30D0-4514-B329-721A4BE81133 Q35370240-ADF26D51-5E1C-4DFD-85BC-D5176758DF24 Q35764145-89534566-85F7-471F-AFD3-5296467131CC Q36018001-80D13700-67DC-40F2-84B5-E37E131CE509 Q36580034-98635565-95E2-41FB-95A8-0DB91374BAAE Q36813817-756D73E3-6FCE-45D3-BD87-DC6FA1502E36 Q36855608-69BAE7CA-61F4-451E-A072-046ABE63A5FF Q36986803-CD35E22D-19BF-45C8-A386-3CACC6FA68F5 Q37167282-A1D2FF60-2617-4F96-81A3-E753652018A4 Q37345384-4B247E86-D6BB-4A04-94F8-FB0528C79289 Q37434574-75030DA1-0CE7-4E64-8150-1ED748579D70 Q37715233-57E3A491-10EE-487E-B4DD-95B779042626 Q38104273-A4ED2BE3-8EA8-4210-8C53-D54EAA60DAEE Q38616806-CDF6931C-3E91-49A6-9537-FAB36588B3F1 Q39701132-FCBE8D2F-FEF3-418D-A384-EC3FA3735C2F Q41096175-69F1DC8A-77CB-45C2-9B0E-24D3D555D0D8 Q41708603-E5CA7B94-94AD-43DE-91DC-BB81E8E391F6 Q42701943-BF9F8805-4B19-423D-AFC1-F8A2851CB53B Q42705932-ED1CE0F3-8842-45BC-9FD1-BA629B366A51 Q42794014-98608AC4-1051-4F56-ACA7-DB43341E1D8E Q43071574-35A22C7C-3742-4C74-9FD7-E54085FA07A2 Q43606515-62779224-F48B-4294-BC10-F0E4789C72B2 Q43676146-E738352E-A2BC-4043-AC9A-02A4D4C9F9C2 Q44495777-43F91491-BEE5-4B51-BEA2-C12059E4C13D Q45058224-B09B2331-B34F-4FF8-921A-DE4C85C63216 Q45213491-D3C868C2-BEAF-48CB-AA23-BD17897C2DD6 Q46239544-F0E82C65-3B92-44E6-B45F-C17C40EB2E33 Q46766394-B5562D2E-FF5F-41B1-BC29-E6E16DD1DC49 Q47232877-C66F61DF-36BE-46F1-AC68-B4F7D6363043 Q47402745-0B2AB1F9-AC5B-48B8-A0C6-B17833A478B1 Q47961774-8722D47B-0773-4F3C-BAD4-C67D03869407 Q48058245-66DEFCD3-34C6-461A-A39A-A4DDF837A5CC Q50993101-43475E13-08A9-4C3A-AA45-37D1731ACB53 Q51598231-262BA430-0039-44D3-9443-7512953AC038 Q51653421-57ED4465-AB7A-402F-A5C9-419408C97280 Q55017266-5C2547E9-BB86-416A-9BD1-3ABBE3CE4EC1

P2860

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

http://www.wikidata.org/entity/Q54684440

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

@en

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

@nl

type

label

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

@en

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

@nl

prefLabel

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

@en

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

@nl

P1433

Q54684440-5396BCF2-C1C8-4A4F-A540-C75372E05F92

P1476

Q54684440-641D6250-D38F-45B4-8526-12699A502A29

P2093

Q54684440-1AFE3BA9-B1A7-431A-AFE4-32075A1EC422

Q54684440-2FAD7E6F-95C6-461C-85B7-A539E6E067F4

Q54684440-5DE77A6F-D525-4999-8440-74A5172035FB

Q54684440-6E11295D-8954-4286-B889-C1F228C38DE6

Q54684440-860A7B1A-055B-401B-A24A-41EFEE1841E6

Q54684440-8C3D1300-75AA-4A98-BDE8-71792202C3C6

Q54684440-B76C3E33-03B0-4524-8665-D99A25A263A2

Q54684440-DB406486-4E67-4A91-8A55-AEE117E12CD9

Q54684440-F92E6A37-6A47-4AC9-879A-B5298622B5A8

P2860

Q54684440-189DC364-576E-4BF1-A060-26F191B4BFEE

Q54684440-1E65E0D3-AF9D-4B86-8744-E7C1DAD7BD38

Q54684440-40E5FD97-5E51-4F18-A484-CA692C13E8A8

Q54684440-73621B3F-DFC8-47E6-9826-AF88925311AB

Q54684440-8B59F7B2-22B1-4A2F-9EC9-CC511768A59D

Q54684440-95E0DCBE-8DB3-4F7E-8C4F-576E2328ED74

Q54684440-BCA5F57D-1972-4A13-AE99-08F4F19A1C21

Q54684440-C424DE71-F19F-44F1-9C42-F28F029FADE7

Q54684440-D4BAD330-01D0-4D8D-888B-CCAAEDC7DD81

P304

Q54684440-AE3E556C-62FF-4765-A4F8-6EBFC49C02A1

P31

Q54684440-E94269A1-66A0-4341-827F-8B137C4ADB4D

P356

Q54684440-2CA8F200-438E-446E-8CB7-B42A8EF90BB8

P433

Q54684440-0FE6E408-DBC4-45C6-A20F-B7C98CFE7524

P478

Q54684440-66A4FACE-B8E1-47C8-94E8-9EB6B9C1E8ED

P577

Q54684440-CA3AD32D-1F54-457A-8556-ACE4F87E27C2

P698

Q54684440-3F1E1711-EB64-4FA3-AAA1-62C97F991479

P921

Q54684440-7C1505DD-CF7E-4760-8F8F-3AE67CBD0015

P356

J.1472-8206.2004.00307.X

P1433

Fundamental and Clinical Pharmacology

P1476

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

@en

P2093

Adithan Chandrasekaran

http://www.w3.org/2001/XMLSchema#string

Anitha Peter

http://www.w3.org/2001/XMLSchema#string

Benny K Abraham

http://www.w3.org/2001/XMLSchema#string

K Satyanarayanamoorthy

http://www.w3.org/2001/XMLSchema#string

Krishnamoorthy Rajagopal

http://www.w3.org/2001/XMLSchema#string

Nathalie Gerard

http://www.w3.org/2001/XMLSchema#string

Rosemary Jose

http://www.w3.org/2001/XMLSchema#string

Shashindran Chanolean

http://www.w3.org/2001/XMLSchema#string

Soya Sisy Sam

http://www.w3.org/2001/XMLSchema#string

P2860

CYP2C9 allelic variants: ethnic distribution and functional significance

Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

Metabolic disposition of proguanil in extensive and poor metabolisers of S-mephenytoin 4'-hydroxylation recruited from an Indonesian population.

Pharmacogenetics of the major polymorphic metabolizing enzymes.

Allele and genotype frequency of CYP2C19 in a Tamilian population.

Association between blood carisoprodol:meprobamate concentration ratios and CYP2C19 genotype in carisoprodol-drugged drivers: decreased metabolic capacity in heterozygous CYP2C19*1/CYP2C19*2 subjects?

Allele and genotype frequency of CYP2C9 in Tamilnadu population.

Genetic variations of S-mephenytoin 4'-hydroxylase (CYP2C19) in the Chinese population.

P304

101-105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1472-8206.2004.00307.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15660966

http://www.w3.org/2001/XMLSchema#string

P921